Corrado Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Corrado Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-550	Closed	-$786	–	403
2022 Q4	$786	Buy	+550	New	+$1.07K	﹤0.01%	369
2021 Q4	–	Sell	-19,366	Closed	-$69K	–	103
2021 Q3	$69K	Sell	19,366 -3,590	-16%	-$12K	0.04%	97
2021 Q2	$73K	Sell	22,956 -23,860	-51%	-$75K	0.05%	94
2021 Q1	$161K	Sell	46,816 -21,850	-32%	-$68K	0.12%	91
2020 Q4	$173K	Sell	68,666 -31,125	-31%	-$67.8K	0.13%	88
2020 Q3	$210K	Sell	99,791 -5,623	-5%	-$13.4K	0.17%	84
2020 Q2	$236K	Sell	105,414 -76,601	-42%	-$197K	0.21%	71
2020 Q1	$460K	Sell	182,015 -5,295	-3%	-$13K	0.43%	42
2019 Q4	$493K	Sell	187,310 -8,999	-5%	-$26.9K	0.44%	42
2019 Q3	$707K	Sell	196,309 -2,235	-1%	-$7.91K	0.64%	38
2019 Q2	$669K	Sell	198,544 -19,259	-9%	-$67.8K	0.6%	36
2019 Q1	$595K	Sell	217,803 -5,980	-3%	-$19.6K	0.55%	36
2018 Q4	$622K	Sell	223,783 -106,310	-32%	-$348K	0.61%	39
2018 Q3	$1.36M	Sell	330,093 -15,702	-5%	-$71.3K	0.89%	33
2018 Q2	$1.79M	Buy	345,795 +36,917	+12%	+$225K	1.09%	27
2018 Q1	$1.69M	Buy	308,878 +64,584	+26%	+$455K	1.02%	29
2017 Q4	$1.99M	Buy	244,294 +5,568	+2%	+$53.2K	1.16%	29
2017 Q3	$2.5M	Sell	238,726 -87,375	-27%	-$970K	1.41%	27
2017 Q2	$3.6M	Buy	326,101 +12,190	+4%	+$114K	1.97%	16
2017 Q1	$2.63M	Buy	313,911 +300,696	+2,275%	+$2.12M	1.51%	22
2016 Q4	$92K	Buy	13,215 +300	+2%	+$1.92K	0.06%	104
2016 Q3	$66K	Buy	+12,915	New	+$77.1K	0.04%	105
2016 Q2	–	Sell	-10,700	Closed	-$49K	–	107
2016 Q1	$49K	Buy	+10,700	New	+$47.6K	0.03%	89

Other funds holding ENZ

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Corrado Advisors's ENZ Position: Q1 2023 in Review

Corrado Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 550 shares — an estimated $786 sold.

Corrado Advisors first reported a position in ENZ in Q1 2016 and held it in 23 quarters. The position peaked at $3.6M in Q2 2017. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

Corrado Advisors reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
Corrado Advisors sold 550 Enzo Biochem, Inc. shares in Q1 2023, an estimated $786.
Corrado Advisors first reported a position in Enzo Biochem, Inc. in Q1 2016 and held it in 23 quarters.
Corrado Advisors's Enzo Biochem, Inc. position peaked at $3.6M in Q2 2017.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Corrado Advisors's 13F filing for Q1 2023, filed 3 May 2023.